Kanuma® (sebelipase alfa)
| Full Name | Kanuma® (sebelipase alfa) |
| Drug | Kanuma |
| Manufacturer | Alexion Pharmaceuticals, a subsidiary of AstraZeneca |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | The treatment of patients with a diagnosis of Lysosomal Acid Lipase (LAL) deficiency |
| Disease | Lysosomal Acid Lipase Deficiency (LAL-D) |
| Therapeutic Area | Neurology, Genetics |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-240-9572 |
| Fax Number | 877-220-7581 |
| Product Website | kanuma.com/hcp |